Literature DB >> 15740464

Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides.

G Isacsson1, P Holmgren, J Ahlner.   

Abstract

OBJECTIVE: To test the hypothesis that selective serotonin reuptake inhibitor (SSRI) antidepressants may have a suicide emergent effect, particularly in children and adolescents.
METHOD: Detections of different antidepressants in the forensic toxicological screening of 14 857 suicides were compared with those in 26,422 cases of deaths by accident or natural causes in Sweden 1992-2000.
RESULTS: There were 3411 detections of antidepressants in the suicides and 1538 in the controls. SSRIs had lower odds ratios than the other antidepressants. In the 52 suicides under 15 years, no SSRIs were detected. In 15-19-year age group, SSRIs had lower relative risk in suicides compared with non-SSRIs.
CONCLUSION: The hypothesis that treatment of depressed individuals with SSRIs leads to an increased risk of suicide was not supported by this analysis of the total suicidal outcome of the nationwide use of SSRIs in Sweden over a period of 9 years, either in adults or in children or adolescents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15740464     DOI: 10.1111/j.1600-0447.2004.00504.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  35 in total

Review 1.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  Toxicological findings in suicides - frequency of antidepressant and antipsychotic substances.

Authors:  Maximilian Methling; Franziska Krumbiegel; Sven Hartwig; Maria K Parr; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2018-11-05       Impact factor: 2.007

Review 3.  Antidepressant use in ambulatory cancer patients.

Authors:  H Florence Kim; Michael J Fisch
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

Review 4.  [Antidepressants and suicidality. Risk-benefit analysis].

Authors:  U Hegerl
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

5.  Association of suicide and antidepressant prescription rates in Japan, 1999-2003.

Authors:  Atsuo Nakagawa; Michael F Grunebaum; Steven P Ellis; Maria A Oquendo; Haruo Kashima; Robert D Gibbons; J John Mann
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384

6.  Safe use of SSRIs in young adults: how strong is evidence for new suicide warning?

Authors:  Michael F Grunebaum; J John Mann
Journal:  Curr Psychiatr       Date:  2007-11

7.  2008 position paper on using SSRIs in children and adolescents.

Authors:  E Jane Garland; Stan Kutcher; Adil Virani
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-05

8.  Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort.

Authors:  Jari Haukka; Martti Arffman; Timo Partonen; Sinikka Sihvo; Marko Elovainio; Jari Tiihonen; Jouko Lönnqvist; Ilmo Keskimäki
Journal:  Eur J Clin Pharmacol       Date:  2009-03-05       Impact factor: 2.953

Review 9.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

Review 10.  Early pharmacological treatment of autism: a rationale for developmental treatment.

Authors:  Terrence C Bethea; Linmarie Sikich
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.